Table: RaQualia Pharma -Q1 group results

RaQualia Pharma

15/05/2023 07:30

May 15 (Reuters)- 
             RaQualia Pharma Inc 
             CONSOLIDATED FINANCIAL HIGHLIGHTS 
     (in billions of yen unless specified)                
                 3 months ended      3 months ended       Year to 
                Mar 31, 2023        Mar 31, 2022     Dec 31, 2023 
                   LATEST             YEAR-AGO          LATEST    
                   RESULTS             RESULTS         FORECAST   
  Sales            370 mln             339 mln           2.80     
                 (+9.2 pct)          (-48.3 pct)      (-4.1 pct)  
  Operating     loss 108 mln        loss 119 mln        260 mln   
                                                      (-69.9 pct) 
  Recurring     loss 110 mln         loss 70 mln        242 mln   
                                                      (-73.2 pct) 
  Net           loss 148 mln        loss 120 mln        183 mln   
                                                      (-74.7 pct) 
  EPS           loss 6.88 yen       loss 5.77 yen      8.74 yen   
  Ann Div                                NIL              NIL     
  -Q2 div                                NIL              NIL     
  -Q4 div                                NIL              NIL     
  
  NOTE - RaQualia Pharma Inc. 
  To see Company Overview page, click reuters://REALTIME/verb=CompanyData/ric=4579.T